NEKTAR THERAPEUTICS Contracts & Agreements

167 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
AGREEMENT AND PLAN OF MERGER Dated as of August 12, 2005
Merger Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
DE
2005
Asset Purchase Agreement, dated as of November 1, 2024, between Nektar and Purchaser
Purchase Agreements
NEKTAR THERAPEUTICS
2024
Nektar Therapeutics Amended and Restated 2017 Performance Incentive Plan, as amended
Bonus & Incentive Agreements
NEKTAR THERAPEUTICS
2024
Amendment No. 1 to Purchase and Sale Agreement, dated December 16, 2020, by and between entities managed by Healthcare Royalty Management, LLC and Nektar Therapeutics
Purchase Agreements
NEKTAR THERAPEUTICS
2024
Form of Pre-Funded Warrant
Warrant Agreements
NEKTAR THERAPEUTICS
2024
Securities Purchase Agreement, dated March 4, 2024, by and between Nektar Therapeutics and TCG Crossover Fund II, L.P
Purchase Agreements
NEKTAR THERAPEUTICS
2024
Letter Agreement dated as of September 6, 2023 by and between Bristol-Myers Squibb and Company and Nektar Therapeutics
NEKTAR THERAPEUTICS
2023
Employment Separation and Release Agreement effective as of June 19, 2023 by and between Nektar Therapeutics and Jillian B. Thomsen
Separation Agreements
NEKTAR THERAPEUTICS
2023
Nektar Therapeutics Amended and Restated 2017 Performance Incentive Plan, as amended
Bonus & Incentive Agreements
NEKTAR THERAPEUTICS
2023
Consulting Agreement between Nektar Therapeutics and FLG Partners, LLC dated April 7, 2023
Consulting Agreements
NEKTAR THERAPEUTICS
2023
Nektar Therapeutics Amended and Restated 2017 Performance Incentive Plan, as amended
Bonus & Incentive Agreements
NEKTAR THERAPEUTICS
2022
Employment Transition, Separation and Consultation Agreement, dated as of June 29, 2022, by and between Nektar Therapeutics and John Northcott
Separation Agreements
NEKTAR THERAPEUTICS
2022
Amendment No. 2 to Strategic Collaboration Agreement dated as of January 12, 2022, by and between Bristol-M
Collaboration Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
2022
Nektar Therapeutics Amended and Restated 2017 Performance Incentive Plan, as amended
Bonus & Incentive Agreements
NEKTAR THERAPEUTICS
2021
Co-Development Agreement, dated as of February 1
NEKTAR THERAPEUTICS
2021
Purchase and Sale Agreement, dated December 16, 2020, by and between entities managed by Healthcare Royalty Management, LLC and Nektar Therapeutics
Purchase Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
NY
2021
Nektar Therapeutics Amended and Restated 2017 Performance Incentive Plan, as amended
Bonus & Incentive Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
2020
Nektar Therapeutics Amended and Restated Employee Stock Purchase Plan
Stock Agreements
NEKTAR THERAPEUTICS
2020
Amended and Restated Compensation Plan for Non-Employee Directors
Compensation Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
2020
Description of Securities
NEKTAR THERAPEUTICS
2020
Transition, Separation and General Release Agreement, dated as of January 9, 2020, by and between Stephen K. Doberstein and Nektar Therapeutics
Separation Agreements
NEKTAR THERAPEUTICS
2020
Employment Agreement effective as of December 4, 2019, by and between Nektar Therapeutics and John Northcott
Employment Agreements
NEKTAR THERAPEUTICS
2020
Amendment No. 1 to Strategic Collaboration Agreement dated as of January 9, 2020, by and between Bristol-Myers Squibb and Company and Nektar Therapeutics
Collaboration Agreements
NEKTAR THERAPEUTICS
2020
Separation, Consulting and General Release Agreement
Consulting Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
2019
Forms of Stock Option Agreement, Performance Stock Option Agreement, Non-Employee Director Stock Option Agreement, Restricted Stock Unit Agreement, Performance Restricted Stock...
Bonus & Incentive Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
DE
2019
Nektar Therapeutics Amended and Restated 2017 Performance Incentive Plan
Bonus & Incentive Agreements
NEKTAR THERAPEUTICS
2018
Investor Agreement, dated as of February 13, 2018, by and between Bristol-Myers Squibb and Company and Nektar Therapeutics
NEKTAR THERAPEUTICS
Pharmaceuticals
DE
2018
Forms of Stock Option Agreement, Performance Stock Option Agreement, Non-Employee Director Stock Option Agreement, Restricted Stock Unit Agreement, Performance Restricted Stock...
Bonus & Incentive Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
DE
2018
Separation and General Release Agreement dated as of December 20, 2017, by and between Nektar Therapeutics and Ivan Gergel, M.D
Separation Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
CA
2018
Share Purchase Agreement dated February 13, 2018, by and between Nektar Therapeutics and Bristol-Myers Squibb Company
Share Agreements
NEKTAR THERAPEUTICS
2018
License Agreement effective as of August 23, 2017, by and between Eli Lilly and Company and Nektar Therapeutics
License Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
2017
Lease Agreement dated August 4, 2017, as amended by the First Amendment to Lease dated as of August 29, 2017, by and between ARE-San Francisco No. 19, LLC and Nektar Therapeutics
Lease Agreements
NEKTAR THERAPEUTICS
2017
Nektar Therapeutics 2017 Performance Incentive Plan
Bonus & Incentive Agreements
NEKTAR THERAPEUTICS
2017
CLINICAL TRIAL COLLABORATION AGREEMENT
Collaboration Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
NY
2016
NEKTAR THERAPEUTICS 13,000,000Shares of Common Stock, $0.0001 par value per share Underwriting Agreement
Underwriting Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
NY
2016
COLLABORATION AND LICENSE AGREEMENT by and between DAIICHI SANKYO EUROPE GMBH and NEKTAR THERAPEUTICS DATE: May 30, 2016
Collaboration Agreements
NEKTAR THERAPEUTICS
2016
AMENDED AND RESTATED COMPENSATION PLAN FOR NON-EMPLOYEE DIRECTORS
Compensation Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
2016
NektarTherapeutics 2012Performance Incentive Plan StockOption Agreement (USOptionholders)
Bonus & Incentive Agreements
NEKTAR THERAPEUTICS
2015
NektarTherapeutics 2012Performance Incentive Plan PerformanceStock Option Agreement
Bonus & Incentive Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
2015
NektarTherapeutics 2012Performance Incentive Plan RestrictedStock Unit Agreement
Bonus & Incentive Agreements
NEKTAR THERAPEUTICS
2015
NektarTherapeutics 2012Performance Incentive Plan PerformanceRestricted Stock Unit Agreement
Bonus & Incentive Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
DE
2015
$250,000,000 Nektar Therapeutics 7.750% Senior Secured Notes due 2020 PURCHASE AGREEMENT
Note Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
NY
2015
NEKTAR THERAPEUTICS 7.75% SENIOR SECURED NOTES DUE 2020
Note Agreements
NEKTAR THERAPEUTICS
2015
PLEDGE AND SECURITY AGREEMENT
Security Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
NY
2015
NEKTAR THERAPEUTICS 2012 PERFORMANCE INCENTIVE PLAN
Bonus & Incentive Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
DE
2015
NektarTherapeutics EmployeeStock Purchase Plan Adoptedby the Board of Directors February 10, 1994 Approvedby Stockholders February 18, 1994 Amendedand Restated May 10, 2002...
Purchase Agreements
NEKTAR THERAPEUTICS
2014
EMPLOYMENT TRANSITION AND GENERAL RELEASE AGREEMENT
Transition Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
CA
2014
TERM LOAN AND SECURITY AGREEMENT among NEKTAR THERAPEUTICS, as Borrower, theGuarantors from time to time party hereto, as Guarantors, and ASTRAZENECA AB, as Agent October 7, 2013...
Loan Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
DE
2014
NEKTAR THERAPEUTICS 8,500,000Shares of Common Stock, $0.0001 par value per share Underwriting Agreement
Underwriting Agreements
NEKTAR THERAPEUTICS
2014
AMENDMENT NO. 1 TO LICENSE AGREEMENT
License Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
NY
2013
NEKTAR THERAPEUTICS 2012 PERFORMANCE INCENTIVE PLAN STOCK OPTION AGREEMENT (US OPTIONHOLDERS)
Bonus & Incentive Agreements
NEKTAR THERAPEUTICS
2013
AMENDED AND RESTATED COMPENSATION PLAN FOR NON-EMPLOYEE DIRECTORS
Compensation Agreements
NEKTAR THERAPEUTICS
2013
PLEDGE AND SECURITY AGREEMENT
Security Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
NY
2013
NEKTAR THERAPEUTICS 12.00% SENIOR SECURED NOTES DUE 2017 INDENTURE Dated as of July 11, 2012 Wells Fargo Bank, National Association Trustee and Collateral Agent
Indenture Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
DE
2012
PLEDGE AND SECURITY AGREEMENT
Security Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
NY
2012
ESCROW AND DEPOSIT ACCOUNT CONTROL AGREEMENT among NEKTAR THERAPEUTICS, WELLS FARGO BANK, NATIONAL ASSOCIATION as Collateral Agent, and WELLS FARGO BANK, NATIONAL ASSOCIATION as...
Deposit Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
2012
$125,000,000 Nektar Therapeutics 12.000% Senior Secured Notes due 2017 PURCHASE AGREEMENT
Note Agreements
NEKTAR THERAPEUTICS
2012
NEKTAR THERAPEUTICS 2012 PERFORMANCE INCENTIVE PLAN
Bonus & Incentive Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
DE
2012
PURCHASE AND SALE AGREEMENT dated as of February 24, 2012 between NEKTAR THERAPEUTICS and RPI FINANCE TRUST
Purchase Agreements
NEKTAR THERAPEUTICS
2012
NEKTAR THERAPEUTICS (formerly known as Inhale Therapeutic Systems, Inc.) 2000 NON-OFFICER EQUITY INCENTIVE PLAN Adopted August 18, 1998 Amended February 23, 1999 Amended December...
Bonus & Incentive Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
DE
2012
NEKTAR THERAPEUTICS (formerly known as Inhale Therapeutic Systems, Inc.) 2000 EQUITY INCENTIVE PLAN Adopted February 10, 1994 Approved By Shareholders February 18, 1994 Amended...
Bonus & Incentive Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
DE
2012
NEKTAR THERAPEUTICS 2008 EQUITY INCENTIVEPLAN Adopted by the Board of Directors on March 20, 2008 Approved by the Shareholders on June 6, 2008 Amended by the Board of Directors on...
Shareholders Agreements
NEKTAR THERAPEUTICS
2012
AMENDED AND RESTATED COMPENSATION PLAN FOR NON-EMPLOYEE DIRECTORS
Compensation Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
2012
Nektar Discretionary Incentive Compensation Policy
Bonus & Incentive Agreements
NEKTAR THERAPEUTICS
2012
NEKTAR THERAPEUTICS AMENDED AND RESTATED CHANGE OF CONTROL SEVERANCE BENEFIT PLAN PLAN DOCUMENT AND SUMMARY PLAN DESCRIPTION NEKTAR THERAPEUTICS AMENDED AND RESTATED CHANGE OF...
Change of Control Agreements
NEKTAR THERAPEUTICS
2012
NEKTAR THERAPEUTICS AMENDED AND RESTATED CHANGE OF CONTROL SEVERANCE BENEFIT PLAN PLAN DOCUMENT AND SUMMARY PLAN DESCRIPTION NEKTAR THERAPEUTICS AMENDED AND RESTATED CHANGE OF...
Change of Control Agreements
NEKTAR THERAPEUTICS
2011
improve efficacy or safety in certain instances as a result of better pharmacokinetics, pharmacodynamics, longer half-life and sustained exposure of the drug
NEKTAR THERAPEUTICS
2011
improve efficacy or safety in certain instances as a result of better pharmacokinetics, pharmacodynamics, longer half-life and sustained exposure of the drug
NEKTAR THERAPEUTICS
Pharmaceuticals
DE
2011
improve efficacy or safety in certain instances as a result of better pharmacokinetics, pharmacodynamics, longer half-life and sustained exposure of the drug
NEKTAR THERAPEUTICS
Pharmaceuticals
2011
improve efficacy or safety in certain instances as a result of better pharmacokinetics, pharmacodynamics, longer half-life and sustained exposure of the drug
NEKTAR THERAPEUTICS
2011
improve efficacy or safety in certain instances as a result of better pharmacokinetics, pharmacodynamics, longer half-life and sustained exposure of the drug
NEKTAR THERAPEUTICS
2011
improve efficacy or safety in certain instances as a result of better pharmacokinetics, pharmacodynamics, longer half-life and sustained exposure of the drug
NEKTAR THERAPEUTICS
Pharmaceuticals
DE
2011
improve efficacy or safety in certain instances as a result of better pharmacokinetics, pharmacodynamics, longer half-life and sustained exposure of the drug
NEKTAR THERAPEUTICS
Pharmaceuticals
2011
improve efficacy or safety in certain instances as a result of better pharmacokinetics, pharmacodynamics, longer half-life and sustained exposure of the drug
NEKTAR THERAPEUTICS
2011
improve efficacy or safety in certain instances as a result of better pharmacokinetics, pharmacodynamics, longer half-life and sustained exposure of the drug
NEKTAR THERAPEUTICS
2011
19,000,000Shares NEKTARTHERAPEUTICS CommonStock ($0.0001par value per Share) UNDERWRITINGAGREEMENT
Share Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
NY
2011
SEPARATION AND GENERALRELEASE AGREEMENT
Separation Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
CA
2010
NEKTARTHERAPEUTICS AMENDEDAND RESTATED CHANGE OF CONTROL SEVERANCE BENEFIT PLAN PLANDOCUMENT AND SUMMARY PLAN DESCRIPTION NEKTARTHERAPEUTICS AMENDEDAND RESTATED CHANGEOF CONTROL...
Change of Control Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
2010
NektarTherapeutics EmployeeStock Purchase Plan Adoptedby the Board of Directors February 10, 1994 ApprovedbyStockholders February 18, 1994 Amendedand Restated May 10, 2002...
Purchase Agreements
NEKTAR THERAPEUTICS
2010
Nektar DiscretionaryIncentive Compensation Policy
Compensation Agreements
NEKTAR THERAPEUTICS
2010
AMENDEDAND RESTATED COMPENSATIONPLAN FOR NON-EMPLOYEE DIRECTORS
NEKTAR THERAPEUTICS
2009
SEPARATION AND GENERALRELEASE AGREEMENT
Separation Agreements
NEKTAR THERAPEUTICS
2009
LICENSEAGREEMENT byand between ASTRAZENECAAB and NEKTARTHERAPEUTICS DATE:September20, 2009
NEKTAR THERAPEUTICS
2009
SUBLEASE
Lease Agreements
NEKTAR THERAPEUTICS
2009
improve efficacy or safety in certain instances as a result of better pharmacokinetics, pharmacodynamics, longer half-life and sustained exposure of the drug
NEKTAR THERAPEUTICS
Pharmaceuticals
CA
2009
improve efficacy or safety in certain instances as a result of better pharmacokinetics, pharmacodynamics, longer half-life and sustained exposure of the drug
NEKTAR THERAPEUTICS
2009
improve efficacy or safety in certain instances as a result of better pharmacokinetics, pharmacodynamics, longer half-life and sustained exposure of the drug
NEKTAR THERAPEUTICS
2009
improve efficacy or safety in certain instances as a result of better pharmacokinetics, pharmacodynamics, longer half-life and sustained exposure of the drug
NEKTAR THERAPEUTICS
Pharmaceuticals
2009
improve efficacy or safety in certain instances as a result of better pharmacokinetics, pharmacodynamics, longer half-life and sustained exposure of the drug
NEKTAR THERAPEUTICS
Pharmaceuticals
DE
2009
improve efficacy or safety in certain instances as a result of better pharmacokinetics, pharmacodynamics, longer half-life and sustained exposure of the drug
NEKTAR THERAPEUTICS
2009
improve efficacy or safety in certain instances as a result of better pharmacokinetics, pharmacodynamics, longer half-life and sustained exposure of the drug
NEKTAR THERAPEUTICS
Pharmaceuticals
2009
improve efficacy or safety in certain instances as a result of better pharmacokinetics, pharmacodynamics, longer half-life and sustained exposure of the drug
NEKTAR THERAPEUTICS
Pharmaceuticals
2009
improve efficacy or safety in certain instances as a result of better pharmacokinetics, pharmacodynamics, longer half-life and sustained exposure of the drug
NEKTAR THERAPEUTICS
2009
improve efficacy or safety in certain instances as a result of better pharmacokinetics, pharmacodynamics, longer half-life and sustained exposure of the drug
NEKTAR THERAPEUTICS
Pharmaceuticals
AL
2009
improve efficacy or safety in certain instances as a result of better pharmacokinetics, pharmacodynamics, longer half-life and sustained exposure of the drug
NEKTAR THERAPEUTICS
Pharmaceuticals
NY
2009
BONUS AND GENERAL RELEASEAGREEMENT
Bonus & Incentive Agreements
NEKTAR THERAPEUTICS
2009
Current assets
NEKTAR THERAPEUTICS
Pharmaceuticals
2008
Current assets
NEKTAR THERAPEUTICS
2008
NEKTAR THERAPEUTICS SEVERANCE BENEFIT PLAN
Severance Agreements
NEKTAR THERAPEUTICS
2008
TERMINATION AGREEMENT AND MUTUAL RELEASE
Termination Agreements
NEKTAR THERAPEUTICS
2008
EXCLUSIVE RESEARCH, DEVELOPMENT,
Development Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
IL
2008
SEPARATION AND GENERAL RELEASE AGREEMENT
Separation Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
DE
2007
NEKTAR THERAPEUTICS, AEROGEN, INC., AND BAYER HEALTHCARE LLC CO-DEVELOPMENT, LICENSE AND CO-PROMOTION AGREEMENT AUGUST 1, 2007
License Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
NY
2007
NEKTAR THERAPEUTICS 2000 EQUITYINCENTIVE PLAN RESTRICTED STOCK UNITAGREEMENT
Stock Agreements
NEKTAR THERAPEUTICS
2007
NEKTAR THERAPEUTICS 2000 EQUITYINCENTIVE PLAN STOCK OPTION AGREEMENT
Stock Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
2007
EMPLOYMENT TRANSITION AND SEPARATION RELEASE AGREEMENT
Separation Agreements
NEKTAR THERAPEUTICS
2007
EMPLOYMENT TRANSITION AND SEPARATION RELEASE AGREEMENT
Separation Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
2007
AMENDED AND RESTATED BUILT-TO-SUIT LEASE
Lease Agreements
NEKTAR THERAPEUTICS
2007
NEKTAR THERAPEUTICS AMENDED AND RESTATED CHANGE OF CONTROL
Change of Control Agreements
NEKTAR THERAPEUTICS
2007
Nektar Discretionary Performance-Based Incentive Compensation Policy
Bonus & Incentive Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
2007
NEKTAR THERAPEUTICS
NEKTAR THERAPEUTICS
2007
COMPENSATION PLAN FOR NON-EMPLOYEE DIRECTORS
Compensation Agreements
NEKTAR THERAPEUTICS
2007
EXHIBIT A EMPLOYEE AGREEMENT
NEKTAR THERAPEUTICS
2007
SETTLEMENT AGREEMENT AND GENERAL RELEASE
Settlement Agreements
NEKTAR THERAPEUTICS
2006
NEKTAR THERAPEUTICS (formerly known as Inhale Therapeutic Systems, Inc.) 2000 EQUITY INCENTIVE PLAN Adopted February 10, 1994 Approved By Shareholders February 18,1994 Amended...
Bonus & Incentive Agreements
NEKTAR THERAPEUTICS
2006
2006 EXECUTIVE COMPENSATION PLAN
Compensation Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
2006
COMPENSATION PLAN FOR NON-EMPLOYEE DIRECTORS
Compensation Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
2006
[Nektar Letterhead]
NEKTAR THERAPEUTICS
2006
NEKTAR THERAPEUTICS 2000 EQUITYINCENTIVE PLAN RESTRICTED STOCK UNIT GRANTNOTICE
Stock Agreements
NEKTAR THERAPEUTICS
2006
NEKTAR THERAPEUTICS 2000 NON-OFFICER EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT GRANT NOTICE
Bonus & Incentive Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
CA
2006
NEKTAR THERAPEUTICS SEVERANCE BENEFIT PLAN
Severance Agreements
NEKTAR THERAPEUTICS
2006
NEKTAR VARIABLE COMPENSATION PLAN
Compensation Agreements
NEKTAR THERAPEUTICS
2006
[Nektar Therapeutics Letterhead]
NEKTAR THERAPEUTICS
Pharmaceuticals
CA
2006
INDENTURE between
Indenture Agreements
NEKTAR THERAPEUTICS
2005
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
NY
2005
NEKTAR THERAPEUTICS (a Delaware corporation) $275,000,000 3.25% Convertible Subordinated Notes due 2012 PURCHASE AGREEMENT
Note Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
DE
2005
COMMON STOCK PURCHASE AGREEMENT
Stock Agreements
NEKTAR THERAPEUTICS
2005
2005 EXECUTIVE COMPENSATION PLAN
Compensation Agreements
NEKTAR THERAPEUTICS
2005
2005 COMPENSATION PLAN FOR NON-EMPLOYEE DIRECTORS
Compensation Agreements
NEKTAR THERAPEUTICS
2005
NEKTAR THERAPEUTICS
NEKTAR THERAPEUTICS
Pharmaceuticals
DE
2005
LICENSE AGREEMENT BETWEEN INHALE THERAPEUTIC SYSTEMS
License Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
DE
2005
DEVELOPMENT ANDLICENSE AGREEMENT
Development Agreements
NEKTAR THERAPEUTICS
2005
Addendum of Offer of Employment
Employment Agreements
NEKTAR THERAPEUTICS
2005
NEKTAR THERAPEUTICS (formerly known as Inhale Therapeutic Systems, Inc.) 2000 NON-OFFICER EQUITY INCENTIVEPLAN Adopted August 18, 1998 Amended February 23, 1999 Amended December...
Stock Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
DE
2004
NEKTAR THERAPEUTICS (formerly known as Inhale Therapeutic Systems, Inc.) 2000 EQUITY INCENTIVE PLAN Adopted February 10, 1994 Approved By ShareholdersFebruary 18, 1994 Amended...
Bonus & Incentive Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
DE
2004
THE CORPORATEPLAN FOR RETIREMENTSM FIDELITY BASIC PLAN DOCUMENT NO. 02 2003 FMR Corp. All rights reserved.
NEKTAR THERAPEUTICS
2004
THECORPORATEPLAN FOR RETIREMENTSM (PROFITSHARING/401(K) PLAN) A FIDELITYPROTOTYPE PLAN Non-StandardizedAdoption Agreement No. 001 For use With FidelityBasic Plan Document No. 02
NEKTAR THERAPEUTICS
Pharmaceuticals
2004
NEKTARTHERAPEUTICS (a Delawarecorporation) 9,500,000 Sharesof Common Stock UNDERWRITINGAGREEMENT
Stock Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
DE
2004
RESALEREGISTRATION RIGHTS AGREEMENT
NEKTAR THERAPEUTICS
2003
PLEDGE AGREEMENT
Pledge Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
NY
2003
EXCHANGEAGREEMENT
Exchange Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
NY
2003
EXCHANGEAGREEMENT
Exchange Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
NY
2003
EXCHANGEAGREEMENT
Exchange Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
NY
2003
FIRSTSUPPLEMENTAL INDENTURE
Indenture Agreements
NEKTAR THERAPEUTICS
2003
PLEDGE AGREEMENT
Pledge Agreements
NEKTAR THERAPEUTICS
2003
EXCHANGEAGREEMENT
Exchange Agreements
NEKTAR THERAPEUTICS
2003
AMENDMENT NO. 1 TO EXCHANGE AGREEMENT
Exchange Agreements
NEKTAR THERAPEUTICS
2003
INDENTURE between NEKTARTHERAPEUTICS, asIssuer and J.P. MORGANTRUST COMPANY, NATIONAL ASSOCIATION asTrustee 3%CONVERTIBLE SUBORDINATED NOTES DUE 2010 Datedas of October 9, 2003...
Indenture Agreements
NEKTAR THERAPEUTICS
2003
RESALEREGISTRATION RIGHTS AGREEMENT
NEKTAR THERAPEUTICS
2003
FORM OF SECURITY [FACE OF SECURITY]
Security Agreements
NEKTAR THERAPEUTICS
2003
PLEDGE AGREEMENT
Pledge Agreements
NEKTAR THERAPEUTICS
2003
EXCHANGEAGREEMENT
Exchange Agreements
NEKTAR THERAPEUTICS
2003
EXCHANGEAGREEMENT
Exchange Agreements
NEKTAR THERAPEUTICS
2003
AMENDMENT NO. 1 TO EXCHANGE AGREEMENT
Exchange Agreements
NEKTAR THERAPEUTICS
2003
AMENDMENT NO. 1 TO EXCHANGE AGREEMENT
Exchange Agreements
NEKTAR THERAPEUTICS
2003
NEKTAR THERAPEUTICS (a Delaware corporation) $100,000,000 3% Convertible Subordinated Notes due 2010 PURCHASE AGREEMENT
Note Agreements
NEKTAR THERAPEUTICS
2003
RESALE REGISTRATIONRIGHTS AGREEMENT among NEKTAR THERAPEUTICS, MERRILL LYNCH, PIERCE,FENNER & SMITH INCORPORATED DEUTSCHEBANK SECURITIES INC. LEHMANBROTHERS INC....
Registration Rights Agreements
NEKTAR THERAPEUTICS
2003
INDENTURE between NEKTARTHERAPEUTICS, asIssuer and J.P. MORGANTRUST COMPANY, NATIONAL ASSOCIATION asTrustee 3%CONVERTIBLE SUBORDINATED NOTES DUE 2010 Datedas of June 30, 2003...
Indenture Agreements
NEKTAR THERAPEUTICS
2003
PLEDGE AGREEMENT
Pledge Agreements
NEKTAR THERAPEUTICS
2003
EMPLOYEERELOCATION REPAYMENT AGREEMENT
NEKTAR THERAPEUTICS
2003
Addendum to Offer of Employment
Employment Agreements
NEKTAR THERAPEUTICS
2003
INHALE THERAPEUTIC SYSTEMS, INC. AND AFACEQUITY, L.P. COMMON STOCK PURCHASE AGREEMENT December 6, 2002 INHALE THERAPEUTIC SYSTEMS, INC. COMMON STOCK PURCHASE AGREEMENT
Stock Agreements
NEKTAR THERAPEUTICS
2003
NEKTARTHERAPEUTICS (FORMERLYKNOWN AS INHALE THERAPEUTIC SYSTEMS, INC.) SEVERANCE BENEFIT PLAN
Severance Agreements
NEKTAR THERAPEUTICS
2003
NUMBER
NEKTAR THERAPEUTICS
2003
INHALETHERAPEUTIC SYSTEMS, INC. AND AFAC EQUITY, L.P. COMMON STOCK PURCHASE AGREEMENT June 7, 2002 INHALETHERAPEUTIC SYSTEMS, INC. COMMONSTOCK PURCHASE AGREEMENT
Stock Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
CA
2002
INHALE THERAPEUTIC SYSTEMS, INC. AND AFAC EQUITY, L.P. COMMON STOCK PURCHASE AGREEMENT July 9, 2002 INHALETHERAPEUTIC SYSTEMS, INC. COMMONSTOCK PURCHASE AGREEMENT
Stock Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
CA
2002
CONFIDENTIAL
NEKTAR THERAPEUTICS
Pharmaceuticals
2002